𝔖 Bobbio Scriptorium
✦   LIBER   ✦

C-myc oncogene product expression and prognosis in operable breast cancer

✍ Scribed by Locker, AP; Dowle, CS; Ellis, IO; Elston, CW; Blamey, RW; Sikora, K; Evan, G; Robins, RA

Book ID
109836263
Publisher
Nature Publishing Group
Year
1989
Tongue
English
Weight
642 KB
Volume
60
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

c-myc oncogene expression in colorectal
c-myc oncogene expression in colorectal cancer
✍ Karol Sikora; Stephen Chan; Gerard Evan; Hani Gabra; Nicholas Markham; Jonathan πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 617 KB
Reproductive history and prognosis in pa
Reproductive history and prognosis in patients with operable breast cancer
✍ Stanislaw Korzeniowski; Tadeusz Dyba πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 355 KB πŸ‘ 3 views

Background. Late menarche, early menopause, high parity, and early first birth decrease the risk of development of breast cancer. The influence of these factors on the survival of breast cancer patients has not been explained. Methods. A group of 1885 patients with operable breast cancer was studie

Circulating antibodies against c-MYC onc
Circulating antibodies against c-MYC oncogene product in sera of colorectal cancer patients
✍ Kamel Ben-Mahrez; IrΓ¨ne Sorokine; Dominique Thierry; Toshiyuki Kawasumi; Sunsuke πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 546 KB

We developed a Western blot assay using purified human c-myc protein expressed in E. coli in order to look for circulating anti-c-myc antibodies in human sera. The presence of IgG antibodies against c-myc was observed in 25 out of 44 sera from patients with colorectal cancer diagnosed and treated at